A 'change' epidemic is gripping pharmaceuticals and it appears to be gathering pace.
Managing the tension between patent expiry and the politics associated with dealing with government funding and gaining reimbursement is creating a complex challenge for the boards of large corporate pharmaceuticals. Add to this, pricing pressures, declining R&D productivity, and stiff competition from generic drug manufacturing and we begin to see something akin to a 'Perfect Storm'.
In these tough times, the companies which will succeed and prosper will be those willing to adapt their business model, particularly through the use of collaborative processes and underpinning technologies. By investing power
in the Chief Information Officer a clear advantage can be won. The right sort of IT leader will simplify time-consuming processes, encourage collaboration and help build and maintain competitive advantage, for the long term.
Les autres publications Heidrick & Struggles